Novartis India Ltd (NOVARTIND) — FY26 Annual Report | 2 September 2026
Novartis India Ltd's 2025-26 Annual Report details the completion of a 70.68% stake sale to WaveRise, ChrysCapital Fund X, and Two Infinity Partners on July 29, 2026, ending Novartis AG's promoter status. The AGM on September 24, 2026, will regularize new director appointments including Ashok Bhatia, Kshitij Sheth, Dr. Jagriti Gupta, Ramesh Ramadurai, and Shashank Sinha. The report outlines remuneration for directors, an ESOP scheme for 1.67 million shares, and a proposed name change to Evonile Pharma Limited. Financials show revenue of ₹3,543.3 million and PAT of ₹931.8 million, with no dividend recommended due to pending share transactions.
About Novartis India Ltd (NOVARTIND)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when NOVARTIND files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NOVARTIND — Free💡 Ask AI about this filing
📊 More NOVARTIND filings
- 🔴 Announcement — 12 September 2026 Novartis India announced that the audio recording of its September 11, 2026 analyst call is now avai...
- 🔴 Announcement — 11 September 2026 Novartis India Limited announced its investor presentation for the September 11, 2026 analyst call, ...
- 🔴 Annual Report — 9 September 2026 Novartis India announced that its 78th Annual General Meeting will be held on September 24, 2026 via...
- 🔴 Announcement — 8 September 2026 Novartis India announced an exclusive promotion and distribution agreement with Novartis Healthcare ...
- 🔴 Announcement — 8 September 2026 Novartis India announced an analyst and institutional investor meeting scheduled for September 11, 2...
🔥 Also filed on 2 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NOVARTIND files new disclosures
Track NOVARTIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NOVARTIND — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd